Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Hypoglycemic Agents / Therapeutic Use"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"330 - Economics"
Search alternatives
:
hypoglycemic »
hypoglycemia
,
hyperglycemia
Showing
1
-
9
of
9
Search:
'"Hypoglycemic Agents / Therapeutic Use"'
,
query time: 0.29s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic review report: Dapagliflozin (Forxiga)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
2
Pharmacoeconomic review report: Dapagliflozin (Forxiga)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Insulin glargine and lixisenatide (Soliqua -- Sanofi-Aventis Canada Inc.) : indication : adjunct to diet and exercise to improv...
Published 2019
CADTH
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
5
Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...
Published 2019
CADTH
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
6
Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...
Published 2019
CADTH
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
7
Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol
Published 2012
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
8
Third-line pharmacotherapy for type 2 diabetes : update
Published 2013
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Semaglutide (Ozempic -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, type 2 to improve glycemic control
Published 2019
CADTH
Subjects:
“
...
Hypoglycemic
Agents
/
therapeutic
use
...
”
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
3
Language
English
9
Collection
National Center for Biotechnology Information
9
Author
Canadian Agency for Drugs and Technologies in Health
8
CADTH Canadian Drug Expert Committee
3
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%22Hypoglycemic+Agents+%2F+Therapeutic+Use%22&type=Subject
Send by Email
×
Loading...